CA1015269A - Method for preparing glucuronyl-glucosamino-glycan sulphates exhibiting antilipamic activity - Google Patents

Method for preparing glucuronyl-glucosamino-glycan sulphates exhibiting antilipamic activity

Info

Publication number
CA1015269A
CA1015269A CA202,441A CA202441A CA1015269A CA 1015269 A CA1015269 A CA 1015269A CA 202441 A CA202441 A CA 202441A CA 1015269 A CA1015269 A CA 1015269A
Authority
CA
Canada
Prior art keywords
antilipamic
glucosamino
glucuronyl
glycan
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA202,441A
Other versions
CA202441S (en
Inventor
Pietro Bianchini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opocrin SpA
Original Assignee
Opocrin SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opocrin SpA filed Critical Opocrin SpA
Application granted granted Critical
Publication of CA1015269A publication Critical patent/CA1015269A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA202,441A 1973-06-14 1974-06-13 Method for preparing glucuronyl-glucosamino-glycan sulphates exhibiting antilipamic activity Expired CA1015269A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2537173 1973-06-14

Publications (1)

Publication Number Publication Date
CA1015269A true CA1015269A (en) 1977-08-09

Family

ID=11216494

Family Applications (1)

Application Number Title Priority Date Filing Date
CA202,441A Expired CA1015269A (en) 1973-06-14 1974-06-13 Method for preparing glucuronyl-glucosamino-glycan sulphates exhibiting antilipamic activity

Country Status (9)

Country Link
US (1) US3936351A (en)
JP (1) JPS5035398A (en)
AR (1) AR201869A1 (en)
AU (1) AU7015174A (en)
CA (1) CA1015269A (en)
DE (1) DE2426586A1 (en)
ES (1) ES427177A1 (en)
FR (1) FR2233332A1 (en)
GB (1) GB1436684A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422407A1 (en) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen USE OF HEPARINE DERIVATIVES FOR SELECTIVE EXTRA-CORPORAL PRECIPITATION OF LOW-DENSITY-LIPOPROTEINS FROM FULL SERUM OR PLASMA
ATE98656T1 (en) * 1989-10-04 1994-01-15 Akzo Nv SULPHATED GLYCOSAMINOGLYCURONANS WITH ANTITHROMBOTIC ACTIVITY.
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
WO2004005532A2 (en) * 2002-07-10 2004-01-15 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
IT1401253B1 (en) 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino USE OF SULODEXIDE FOR THE REDUCTION OF MATRIX METALLOPROTEINASE.
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides
EP4182452A1 (en) 2020-07-14 2023-05-24 Optimvia, LLC Methods for synthesizing non-anticoagulant heparan sulfate
RU2759517C9 (en) * 2021-04-02 2022-01-20 Общество с ограниченной ответственностью "АВЕО" Method for obtaining pharmaceutical sulfated glycosaminoglycans from biological tissues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
GB889010A (en) * 1957-11-06 1962-02-07 Crinos Industria Farmaco A new heparin-like compound
US3174903A (en) * 1961-09-14 1965-03-23 Szabo Hnos Kessler & Cia S R L Preparation of heparinoids
LU53450A1 (en) * 1966-07-22 1967-06-19
US3810978A (en) * 1971-12-06 1974-05-14 Taiho Pharmaceutical Co Ltd Process for producing antilipemic substance

Also Published As

Publication number Publication date
JPS5035398A (en) 1975-04-04
AR201869A1 (en) 1975-04-24
FR2233332A1 (en) 1975-01-10
AU7015174A (en) 1975-12-18
DE2426586A1 (en) 1975-01-09
GB1436684A (en) 1976-05-19
US3936351A (en) 1976-02-03
ES427177A1 (en) 1976-07-16

Similar Documents

Publication Publication Date Title
CA1018299A (en) Process for polymerizing -olefines
CA1027695A (en) Method for making polyetherimides
CA1031791A (en) Process for preparing perfluorononanes
CA1015269A (en) Method for preparing glucuronyl-glucosamino-glycan sulphates exhibiting antilipamic activity
CA1021802A (en) 22-dehydro-25-hydroxycholecalciferol and process for preparing same
CA1023346A (en) Process for preparing cephalexin
CA1010028A (en) Process for preparing 2-azacycloalkymethyl ketones
CA1027560A (en) Prostenoic acid derivatives and method for preparing same
CA1031792A (en) Process for preparing perfluoro-2-methyl-pentane
CA1022540A (en) Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
AU474992B2 (en) Reduction process
CA1024995A (en) Process for preparing 5-oxohexane-nitrile
CA1007588A (en) Process for preparing high activity pepsin
CA1012967A (en) Method for preparing sucrose-fixed acetaldehyde
AU471137B2 (en) Steroido-oxazolidines, steroido-oxazolidino-oxazines and method for their preparation
CA1018177A (en) Process for preparing sultones
CA1022539A (en) 22-dehydro-25-hydroxycholecalciferol and process for preparing same
AU492868B2 (en) Polyetherquinoxalines and method for making
AU471136B2 (en) new STEROIDO-OXAZOLIDINES AND METHOD FOR THEIR PREPARATION
AU483888B2 (en) Process for preparing oxaprostaglandins
CA1008857A (en) Process for preparing benzodiazepin-2-ones
AU479783B2 (en) Process for preparing cyclicdicarboximido-substituted phoshonothioates
CA1002940A (en) Process for preparing steroidyl-estratienes
AU453282B2 (en) Process for preparing polythiodiglycol
CA1021775A (en) Method for producing tetrahydrodibenzocyclo-propazepine